×
NewGenIvf Group Net Profit Margin 2023-2023 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
NewGenIvf Group net profit margin from 2023 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
NewGenIvf Group Net Profit Margin 2023-2023 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
NewGenIvf Group net profit margin from 2023 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$151.7B
Elevance Health (ELV)
$90.6B
Cencora (COR)
$47.6B
Natera (NTRA)
$23.1B
DiDi Global (DIDIY)
$22.8B
ICON (ICLR)
$16.2B
Avantor (AVTR)
$14.8B
Revvity (RVTY)
$14.5B
BioMerieux (BMXMF)
$14.3B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.9B
CochLear (CHEOY)
$12.8B
Medpace Holdings (MEDP)
$11.2B
Doximity (DOCS)
$10.9B
EUROFINS SCIENT (ERFSF)
$10B
HealthEquity (HQY)
$9.7B
Sonic Healthcare (SKHHY)
$8.5B
Charles River Laboratories (CRL)
$8.5B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$5.7B
BrightSpring Health Services (BTSG)
$3.9B
Sotera Health (SHC)
$3.9B
Organon (OGN)
$3.8B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.9B
PACS (PACS)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
Teladoc Health (TDOC)
$2.1B
Progyny (PGNY)
$1.9B